Thalidomide Regulation of NF-κB Proteins Limits Tregs Activity in Chronic Lymphocytic Leukemia

Advances in Clinical and Experimental Medicine - Poland
doi 10.17219/acem/37018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wroclaw Medical University

Related search

Constitutive Activation of NF-κB Signaling by NOTCH1 Mutations in Chronic Lymphocytic Leukemia

Oncology Reports
MedicineCancer ResearchOncology
2015English

Proliferation Centers in Chronic Lymphocytic Leukemia: The Niche Where NF-κB Activation Takes Place

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Stealing Tregs’ Identity (By Deleting NF-κB)

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2017English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Chronic Lymphocytic Leukemia

Orvosi Hetilap
Medicine
2008English

Chronic Lymphocytic Leukemia

ASH Image Bank
2003English

Chronic Lymphocytic Leukemia

Molecular and Translational Medicine
2018English

Interdependent Regulation of P53 and miR-34a in Chronic Lymphocytic Leukemia

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2010English

Chronic Lymphocytic Leukemia

Hematology/Oncology Clinics of North America
OncologyHematology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy